Drug name |
Registration No. |
Indications |
Popular experiment questions |
Trial stage |
Recruitment objects |
Test status |
CDE publicity platform |
---|---|---|---|---|---|---|---|
BT-114143 injectable |
CTR20222910 |
Treatment and prevention of various bleeding and diseases caused by hyperfibrinolysis |
Phase I clinical trial of anti-hyperfibrinolytic drugs |
Phase I |
Healthy subjects |